CHRONIC MYELOGENOUS LEUKEMIA: treatments, side effects and outcomes

This report is specific for Chronic Myelogenous Leukemia. 
This 28 page report has 8 sections, which includes basic explanation of the disease state, 5-year survival rate, basic outline of current therapeutic approaches, information on 12 FDA approved drugs for chronic myelogenous leukemia (CML) , outline of the mechanism of action for each drug, outcome of clinical trials measured as response rate, median overall survival and disease progression-free survival, ongoing clinical trials, information on support groups and list of other credible resources to support your own research.